Company: LRHC
Filing Date: 2025-07-17
Form Type: 424B3
Source: 0001213900-25-065175
Chunk: 30

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-17
Form: 424B3
Chunk 30
---
 record holders
of our common stock issued and outstanding. The number of record holders was determined from the records of our transfer agent and does
not include beneficial owners of common stock whose shares are held in the names of various security brokers, dealers, and registered
clearing agencies.

Transfer Agent and Registrar

Our transfer agent and registrar for our common stock is Vstock Transfer, LLC located at 18 Lafayette Place, Woodmere, NY 11598. Their telephone number is (212) 828-8436.

Dividend Policy

The Company has not declared nor paid any cash dividends on its publicly traded common stock after the completion of our IPO in October 2023. We currently intend to retain earnings and profits, if any, to support our business strategy and do not intend to pay any cash dividends within the foreseeable future. Any future determination to pay cash dividends will be at the sole discretion of our Board of Directors and will depend upon the financial condition of the Company, its operating results, capital requirements, general business conditions and any other factors that our Board of Directors deems relevant.

<div align='center'>16

PRIVATE PLACEMENT</div>

Securities Purchase Agreement and Exchange Agreement

As we reported in a Current Report on Form
8-K filed with the SEC on February 5, 2025, on February 4, 2025 (the “Closing Date”) we entered into a securities purchase
agreement (the “SPA”) with the Selling Stockholder pursuant to which we agreed to issue and sell to the Selling Stockholder,
upon the terms and conditions set forth in the SPA: (i) a Senior Secured Convertible Note in the original principal amount of $5,500,000
which matures on the two-year anniversary of the Closing Date (the “Initial Note”); and (ii) sixteen (16) warrants (“Incremental
Warrants”), each to purchase additional Notes in an original principal amount up to $2,500,000 at an exercise price of $2,256,250,
in substantially the same form as the Initial Note (“Incremental Notes” and together with the Initial Note, the “Notes”).
The Incremental Warrants and Initial Note were issued to the Seller Stockholder on the Closing Date. The purchase price paid by the Selling
Stockholder under the SPA for the Initial Note and Incremental Warrants is $4,963,750, which has been or may be used by the Company to
pay-off certain indebtedness, pay certain outstanding fees and expenses,